Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

A mix of methotrexate, corticosteroids, and topical minoxidil effectively treated severe total body hair loss, but caused stretch marks and needs long-term monitoring.

Combining platelet-rich plasma therapy with low dose oral minoxidil improved hair growth in men with hair loss, with slightly higher satisfaction at the higher minoxidil dose.

Using minoxidil and tofacitinib together can effectively treat severe hair loss.

Ciproterone acetate improves hair regrowth and acne in most female patients.

A new lipid-based formula using myristyl myristate can improve estradiol treatment for hair loss.

Mesotherapy is a minimally invasive treatment with potential benefits and risks, requiring standardized practices and further investigation.

The multimodal microemulsion with minoxidil, diclofenac, and tea tree oil is more effective for hair growth than minoxidil alone.

New steroids were patented as effective for treating acne, hair loss, and other conditions related to hormones.

The combination treatment showed some improvement but wasn't significantly better than using betamethasone valerate alone.

Multimodal minoxidil microemulsion is more effective in treating hair loss than minoxidil alone.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

A 25-year-old man with multiple skin tumors was successfully treated with acitretin and methotrexate.

PM-9 and finasteride effectively inhibit the enzyme that converts testosterone to DHT.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

Microinfusion of methotrexate can help treat frontal fibrosing alopecia.

Oral and topical tranexamic acid effectively and safely improve melasma.

Bicalutamide may effectively treat female pattern hair loss with minimal side effects.

Bicalutamide may reduce hair shedding in women but needs longer trials to confirm its effectiveness.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Topical eflornithine effectively reduces unwanted facial hair in women with hirsutism for at least 6 months.

The combined treatment of 3% minoxidil and 0.1% finasteride is more effective in improving hair loss than 3% minoxidil alone, with similar side effects.

YH0618 helps reduce chemotherapy-induced hair loss by targeting specific proteins and pathways.

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

Deuruxolitinib helped regrow eyebrows and eyelashes in a man with resistant alopecia universalis.

Imuvert can prevent some chemotherapy-induced hair loss.

Invasomes with 0.5% limonene greatly improve skin delivery of finasteride.

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.